与PARP抑制剂相关的急性功能衰竭:基于FDA不良事件报告系统数据库的现实研究
Xiayang Ren1, Ping Sun2, Yanfeng Wang3
1Department of Pharmacy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Expert opinion on drug safety
|July 5, 2024
概括
多 (ADP-ribose) 聚合酶抑制剂 (PARPis) 与急性功能衰竭 (ARF) 有关,除了talazoparib. 现实数据显示,PARPis具有显著的ARF风险和延迟反应,需要增加临床关注.
科学领域:
- 药物监督 药物监督 药物监督
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在瘤学瘤学.
背景情况:
- 与PARP抑制剂 (PARPis) 相关的急性功能衰竭 (ARF) 的临床试验数据可能不反映现实世界的情景.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 用于在更广泛的患者群体中评估PARPis相关的ARF.
研究的目的:
- 用现实世界的数据评估PARP抑制剂与急性功能衰竭之间的关联.
- 分析PARPis相关ARF的发病时间和临床结果.
主要方法:
- 分析了FAERS在2015年1月1日至2023年9月30日期间的2726份ARF事件报告.
- 应用四个算法来识别PARPis. 的重要报告信号.
- 评估发病时间和临床结果,包括死亡率和危及生命的不良事件.
主要成果:
- 对olaparib,niraparib和rucaparib检测到显著的ARF信号.
- ARF发病的中位时间不同:57天 (olaparib),36天 (niraparib) 和85天 (rucaparib).
- 与niraparib (2.52%) 和rucaparib (2.94%) 相比,olaparib的死亡比例更高 (9.88%). 与rucaparib (0.98%) 相比,niraparib具有更高比例的危及生命的事件 (4.89%).
结论:
- 在PARP抑制剂和ARF之间存在相关性,不包括talazoparib.
- 与PARPis相关的严重不良事件和延迟反应的高发病率要求更加强大的临床警.
- 现实世界的数据分析对于理解PARPi相关毒性的全谱至关重要.
相关概念视频
01:11Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
01:17Factors Affecting Renal Clearance: Renal Impairment
74
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
74